Results 121 to 130 of about 47,644 (242)

Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This review synthesises current knowledge on gut microbiome involvement in obesity and hypertension, evaluates microbiome‐based therapeutic strategies, and identifies critical research gaps to guide future investigations aimed at mitigating the dual pandemics.
Andrej Belančić   +7 more
wiley   +1 more source

Comparison of four methods for identification of bifidobacteria to the genus level

open access: yesCzech Journal of Food Sciences, 2002
The identification of bifidobacteria to the genus level is important for the differentiation of these bacteria from other bacteria occurring in the animal and human intestine.
E. Vlková, J. Medková, V. Rada
doaj   +1 more source

Co‐Encapsulation of Probiotics With Multiple Bioactives: Stability and Viability of Probiotics

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
ABSTRACT The global demand for functional food containing probiotics is rapidly increasing due to their well‐documented health benefits. However, maintaining the stability and viability of probiotics during processing, storage, and gastrointestinal transit (GIT) remains a persistent challenge.
Poorni Sandupama, Wee Sim Choo
wiley   +1 more source

Fungal Polysaccharides as Next‐Generation Bioactive: Advances in Structure–Activity Mapping, Mode of Action, and Biotechnological Horizons

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
ABSTRACT Fungal polysaccharides (FPs) represent a diverse class of bioactive macromolecules widely studied for their nutritional, therapeutic, and biotechnological value. This review synthesizes recent advances (2020–2025) in the structural characterization, biological functions, and translational potential of FPs.
Muhammad Aaqil   +6 more
wiley   +1 more source

Direct identification of bifidobacteria from probiotic supplements

open access: yesCzech Journal of Food Sciences, 2014
The DNA of 14 probiotic supplements was isolated directly from various products without previous cultivation. The bifidobacteria composition declared by the manufacturer was determined by species-specific PCR.
Věra Bunešová   +5 more
doaj   +1 more source

Inhibition of Escherichia coli by Bifidobacteria

open access: yesJournal of Food Protection, 1993
The ability of five ATCC bifidobacterial species to produce antimicrobial substances was investigated by testing the effects of spent bifidobacterial broths on the growth Escherichia coli in the thioglycollate medium. Such broths were most inhibitory if their pH was not readjusted to neutrality. When that was done, the inhibition ranged from 30 to 43%.
Salam A, Ibrahim, Anatoly, Bezkorovainy
openaire   +2 more sources

Natural Products as the Modulators of Gut Microbiota: A Pool for the Development of New Treatment Against Obesity?

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
Natural compounds regulate gut microbiota by improving microbial balance and increasing probiotics, which boost short‐chain fatty acid production to alleviate insulin resistance and inflammation. Additionally, they stimulate appetite‐suppressing hormones through bile acid signaling, while inhibiting pathogenic bacteria to repair intestinal barrier ...
Hongchao Yuan   +7 more
wiley   +1 more source

BIFIDUM-MEDIUM FOR ISOLATION AND CULTIVATION OF BIFIDOBACTERIA

open access: yesИнфекция и иммунитет, 2014
The comparative evaluation of Bifidum-medium quality (the nutrient medium for cultivation and selection bifidobacteria, dry) and Blaurock medium has been performed.
L. V. Domotenko, A. P. Shepelin
doaj   +1 more source

Conjugated 2′‐Fucosyllactose–Potato Protein Hydrolysate as Novel Prebiotics

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
This study introduces a novel protein‐containing prebiotic based on 2′‐FL‐PPH Maillard conjugates micelles that co‐deliver proteins and carbohydrates to the colon to selectively nourish colonic probiotics. These digestion‐resistant micelles enhanced Bifidobacteria, SCFAs, gut barrier integrity, and metabolic health more effectively than conventional ...
Stav Peled   +4 more
wiley   +1 more source

Parenteral Antibiotics Reduce Bifidobacteria Colonization and Diversity in Neonates

open access: yesInternational Journal of Microbiology, 2011
We investigated the impact of parenteral antibiotic treatment in the early neonatal period on the evolution of bifidobacteria in the newborn. Nine babies treated with intravenous ampicillin/gentamicin in the first week of life and nine controls (no ...
Séamus Hussey   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy